InsiderStreet Equity Research

Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Last Close

$94.98

2026-10-16

Market Cap

$18.1B

Volume

1.9M

52-Wk High

$106.88

52-Wk Low

$79.12

Trailing PE

23.0

P/S

2.13

Gross Margin

69.9%

Net Margin

9.5%

ROE

6%

ROIC

6%

Piotroski

7/9

Altman Z

2.5

1-Yr Return

-5.0%

5-Yr Return

-25.7%

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.

SectorHealthcareIndustryMedical - DevicesExchangeNYSEMarket Cap$18.1BEmployees17,000 (SEC-filed)CEOIvan TornosIPO2001-07-25CountryUS

345 East Main Street, Warsaw, IN 46580 · Tel 574 267 6131 · zimmerbiomet.com

INSIDERSTREET SCORE60 / 100Street mean $105.50 (8 analysts, last qtr) — their number, not ours

INSIDER CONSENSUS SIGNALROUTINE SELLING — LOW SIGNAL$1M sold / 6 mo, zero open-market buys

INSIDERSTREET
SCORE60of 100

Score Breakdown

Profitability	45/100
Growth	44/100
Momentum	74/100
Quality	72/100
Earnings Quality	71/100
Balance Sheet	50/100
Value	65/100
Risk (safety)	50/100
Overall	59.6/100

Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

Symbol	IS Score
PEN	68
SNN	76
ALGN	64
GMED	82
DXCM	81
PODD	71
ZBH	60

IS Score Trend — quarterly

14 quarters, 23 Q1 to 26 Q2. Peak 65 in 24 Q1, latest 60 — -5 since. Fell in 1 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

1 Year vs S&P 500 · ZBH -5.0% · S&P 500 +15.9% · spread -20.8pp

7 Years vs S&P 500 · ZBH -25.7% · S&P 500 +189.9% · spread -215.6pp

Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.

BUSINESS QUALITY60 / 100IS Score 59.6 / 100 · -5.2 from peak of 65

Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.

PRICE STRUCTUREBULLISHTechnical Score 67 / 100 · Power +34 · 17 of 22 indicator votes bullish

Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 60 and price structure at 67 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Trigger	Where it stands now	What it would mean
IS Score reaches 75 and holds two consecutive quarters	now 59.6	would move us up one band
IS Score stops falling - one quarter higher than the prior	last four: 54 → 44 → 57 → 60	the direction matters more than the level
Technical vote share back above 50%	now 82%	price structure no longer broken
Institutional holder count rises two quarters running	peak 1,023 → now 910	fewer institutions willing to hold is our clearest warning

We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Site Convergence Score3 of 4top 4% of 29,420 symbols

Sources Aligned— of 3independent disclosures

Congress (180d)2 buys2026-09-11

Insider Buys (180d)0none disclosed

ETF Funds (30d)919 up / 793 downnet +126 funds

Institutions Added (13F)1managers opening or increasing

Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.

Institutions holding — 12 quarters

Peak 1,023 · latest 910 (-113 from peak).

Quarter	Holders	13F shares	Value	Reported own%	Guard
2026 Q2	910	200.1M	$16.6B	104.1%	ex-outlier 91.5%
2026 Q1	909	192.1M	$16.1B	100.0%
2025 Q4	940	198.6M	$16.1B	103.3%	ex-outlier 91.1%
2025 Q3	960	191.9M	$16.9B	99.8%
2025 Q2	931	192.9M	$15.9B	100.4%
2025 Q1	998	185.1M	$18.8B	96.3%
2024 Q4	1,021	182.6M	$17.1B	95.0%
2024 Q3	975	181.3M	$17.5B	94.3%
2024 Q2	995	186.3M	$18.4B	96.9%
2024 Q1	1,008	185.5M	$22.5B	96.5%
2023 Q4	1,023	182.5M	$20.6B	95.0%
2023 Q3	1,008	183.2M	$19.5B	95.3%

How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

Why 2026-06 reads 104.10%. Institutions cannot hold more of a company than exists. The reported 200.1M shares exceed the 192.2M outstanding, and a single filer accounts for the excess: Dodge & Cox reports 24,124,735 shares against 23,542,700 the prior quarter, a 1x jump, which alone would be 12.6% of the company. Excluding that filing, ownership is 91.5%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.

Why 2025-12 reads 103.34%. Institutions cannot hold more of a company than exists. The reported 198.6M shares exceed the 192.2M outstanding, and a single filer accounts for the excess: Dodge & Cox reports 23,506,849 shares, which alone would be 12.2% of the company. Excluding that filing, ownership is 91.1%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Insider	Role	Date	Type	Shares	Value	Post-Txn Owned
Campbell Gary Craig	President, Americas	2026-10-01	EXERCISE	2,368	—	2,368
Campbell Gary Craig	President, Americas	2026-10-01	TAX W/H	932	$0.08M	1,436
Campbell Gary Craig	President, Americas	2026-10-01	EXERCISE	1,218	—	2,654
Campbell Gary Craig	President, Americas	2026-10-01	TAX W/H	480	$0.04M	2,174
Campbell Gary Craig	President, Americas	2026-10-01	EXERCISE	2,368	—	0
Campbell Gary Craig	President, Americas	2026-10-01	EXERCISE	1,218	—	2,434
Hatcher Brian Matthew	President, Recon, SET, CMFT	2026-10-01	—	6,201	—	0
Hatcher Brian Matthew	President, Recon, SET, CMFT	2026-10-01	—	2,156	$0.26M	0

6-mo decomposition (Form 4)	Txns	Shares	Value	Signal weight
S — Open-market sales	5	16,341	$1.5M	Counted
M — Exercises (paired A/D)	18	76,305	—	None — mechanics
F — Tax withholding	23	57,373	$5.4M	None — compensation
P — Open-market purchases	0	0	$0	Counted — none occurred

Monthly Net Insider Flow (000 shares)

Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalRoutine Selling — Low Signal

Open-Market Sells$1.5M5 txns / 6 mo

Open-Market Buys$0.0M0 txns / 6 mo

ClusterNone active3+ insiders / 21 days

Filed	Filer	Shares registered	Est. proceeds
2026-09-11	Thornal Kevin R	5,691	$0.5M
2026-09-04	Phipps Chad F	3,000	$0.3M
2026-07-16	Upadhyay Suketu	7,668	$0.7M
2026-06-24	Upadhyay Suketu	4,560	$0.4M
Trailing 12 mo	10 filings	67,395	$6M

Filed	Form	Reporting person	% of class	Shares
2026-08-13	SCHEDULE 13G/A	Dodge & Cox	12.50%	24.1M sh
2026-08-12	SCHEDULE 13G	Capital International Investors	6.40%	12.4M sh
2026-05-15	SCHEDULE 13G/A	T. Rowe Price Associates, Inc.	4.10%	8.0M sh
2026-04-30	SCHEDULE 13G	Vanguard Capital Management	7.54%	14.8M sh

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Member	Chamber	Trade	Size band	Traded	Disclosed
Ro Khanna	House	SELL	$1,001 - $15,000	2026-09-14	2026-10-09
Ro Khanna	House	SELL	$1,001 - $15,000	2026-09-14	2026-10-09
Ro Khanna	House	BUY	$1,001 - $15,000	2026-09-11	2026-10-09
Alan Armstrong	Senate	BUY	$1,001 - $15,000	2026-03-27	2026-07-20
John Reed	Senate	SELL	$1,001 - $15,000	2016-12-16	2017-01-04
John Reed	Senate	SELL	$1,001 - $15,000	2016-12-16	2017-01-04

House 12-Mo7 trades2 purchases

Senate 12-Mo1 trades1 purchases

CoverageSTOCK Act filings30-45 day disclosure lag

13F Filers (last complete Q)909

13F Shares192M100.0% of shares out

New / Closed95 / 107positions, QoQ

Increased / Reduced310 / 300positions, QoQ

Put/Call (13F)1.17option positions

Free Float99.8%190M sh

2.8 · Largest Reporting 13F Managers

Manager	Shares	Value
Douglas Lane & Associates, Llc	451,613	$40M
Northside Capital Management, Llc	112,771	$10M
Wealth Enhancement Advisory Servic	80,788	$4M
Mn Services Vermogensbeheer B.V.	56,544	$5M
Gilman Hill Asset Management, Llc	56,464	$5M
Asr Vermogensbeheer N.V.	56,026	$5M

EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

Fund	Weight	Position
VITSX	0.0%	$537M
VTI	0.0%	$537M
VSMPX	0.0%	$537M
VTSAX	0.0%	$537M
VWNFX	0.8%	$505M
VWNAX	0.8%	$505M

13F Filers Holding ZBH — quarterly

Institutional Put/Call — quarterly

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.

Latest Session56.0%2026-10-15

20-Day Avg46.7%50-day 49.4%

TrendFalling20d vs 50d

By Market CenterQ: 56% · N: 61% · B: 41%latest session

Weekly Notional ($B)

Where ZBH Trades in the Dark

ATS Venue (4-wk)	Shares	Avg trade
Incr Intelligent Cross Llc	2.7M	48 sh
Ubsa Ubs Ats	2.4M	53 sh
Bids Bids Ats	1.6M	826 sh
Mstx Ms Trajectory Cross (Ats-1)	1.4M	43 sh
Sgmt Sigma X2	1.4M	43 sh
Ebxl Level Ats	1.4M	26 sh

Where a dollar of Zimmer Biomet Holdings, Inc. revenue goes. All values FY2025 filings, live.

Region	Revenue	Share
Americas	$5.1B	62%
E M E A	$1.8B	22%
Asia Pacific	$1.3B	15%

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

ZBH (live moat model)Peer median: PEN · SNN · ALGN · GMED · DXCM

Component scores from the live moat model. Peer median illustrative.

Moat score 48/100 — Weak; primary source Cost Advantage.

3.8 · Employees (SEC filings)

Officer	Title
Ivan Tornos	President, Chief Executive Officer & Chairman of the Board
JehanZeb Noor	Senior VP, Chief Strategy, Business Development, Innovation & Transformation Officer
Wilfred van Zuilen	Group President of Europe, Middle East & Africa
Chad F. Phipps	Senior VP, Chief Legal & Corporate Affairs Officer and Secretary

Revenue ($B)

EPS ($) — GAAP diluted actual, street-basis estimate

Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Quarterly EPS — Actual vs. Consensus

Beats (>2%)4 of 6recent quarters

Avg Surprise+4.2%

Next Report2026-11-04

Income Quality2.16OCF ÷ net income

Beat Rate—%0 of 0 quarters

Current Streak0longest 0

Avg EPS Surprise—%median —%

Surprise Trend—last 4 vs prior 4

Period	EPS est.	EPS actual	EPS surprise	Rev est. ($M)	Rev actual ($M)	Rev surprise

Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.

Profit Margins (%)

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Revenue by Segment — Stacked

Live segmentation data.

YoY Growth Heatmap — Income Lines

YoY growth	FY21	FY22	FY23	FY24	FY25
Revenue	+11.4%	+1.6%	+6.5%	+3.8%	+7.2%
Gross profit	+13.1%	+1.1%	+7.9%	+3.3%	-7.6%
Operating income	+935.3%	-19.1%	+83.5%	+0.6%	+6.0%
Net income	-389.1%	-42.4%	+342.5%	-11.7%	-22.0%

$B · FY ends	FY21	FY22	FY23	FY24	FY25
Revenue	6.8	6.9	7.4	7.7	8.2
Cost of revenue	2.0	2.0	2.1	2.2	3.2
Gross profit	4.9	4.9	5.3	5.5	5.1
R&D expense	0.4	0.4	0.5	0.4	0.5
SG&A expense	2.8	2.8	2.8	2.9	3.3
Operating income	0.9	0.7	1.3	1.3	1.4
EBITDA	1.6	1.5	2.2	2.3	2.2
D&A	0.9	0.9	1.0	1.0	1.1
Pretax income	0.5	0.4	1.1	1.0	0.8
Income tax	0.1	0.1	0.0	0.1	0.1
Net income	0.4	0.2	1.0	0.9	0.7
Diluted EPS ($)	1.91	1.10	4.88	4.43	3.55
Diluted shares (M)	210	210	210	204	199

Operating CF$2B

CapEx$0B

Free cash flow$1B

SBC$0B

Buybacks$0B

Net cash change$0B

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet — Full

$B	FY22	FY23	FY24	FY25
Cash & equivalents	0.4	0.4	0.5	0.6
ST investments	0.0	0.0	0.0	0.0
Receivables (net)	1.4	1.4	1.5	1.7
Total current assets	4.4	4.6	4.7	5.1
PP&E (net)	1.9	2.1	2.0	2.2
Goodwill + intangibles	13.6	13.7	13.5	14.7
Total assets	21.1	21.5	21.4	23.1
Accounts payable	0.4	0.4	0.2	0.0
Short-term debt	0.5	0.9	0.9	0.6
Deferred revenue	0.0	0.0	0.0	0.0
Total current liabilities	2.4	2.9	2.5	2.6
Long-term debt	5.2	4.9	5.3	6.9
Total liabilities	9.0	9.0	8.9	10.4
Shareholders' equity	12.0	12.5	12.5	12.7

Cash Flow Statement — Full

$B	FY22	FY23	FY24	FY25
Net income	0.3	1.0	0.9	0.7
D&A	0.9	1.0	1.0	1.1
Stock-based compensation	0.1	0.1	0.1	0.0
Working capital change	(0.3)	(0.4)	(0.5)	(0.1)
Operating cash flow	1.3	1.6	1.5	1.7
Capital expenditures	(0.2)	(0.4)	(0.4)	(0.2)
Investing cash flow	(0.5)	(0.8)	(0.9)	(2.0)
Buybacks	(0.1)	(0.7)	(0.9)	(0.5)
Dividends paid	(0.2)	(0.2)	(0.2)	(0.2)
Debt issuance / (repay)	(1.1)	0.1	0.5	1.0
Financing cash flow	(0.8)	(0.8)	(0.5)	0.3
Free cash flow	1.1	1.2	1.1	1.5

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Balance Sheet Structure ($B)

Cash Generation vs Capex ($B)

Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
PROFITABILITY
ROE	3.2%	1.9%	8.4%	7.2%	5.6%	6%
ROA	1.7%	1.0%	4.8%	4.2%	3.2%	3.5%
ROIC	3.9%	2.9%	6.9%	6.2%	5.3%	5.5%
Gross margin	71.3%	70.9%	71.8%	71.5%	61.6%	69.9%
Operating margin	12.6%	10.0%	17.3%	16.7%	16.5%	15.7%
Net margin	5.9%	3.3%	13.8%	11.8%	8.6%	9.5%
EBITDA margin	24.1%	21.5%	30.0%	29.3%	26.9%	27.5%
FCF margin	18.8%	15.8%	16.1%	14.9%	22.5%	—
VALUATION
P/E	62.36	113.38	24.40	23.19	25.26	23.0
P/B	1.98	2.18	2.00	1.68	1.40	1.4
P/S	3.53	3.78	3.38	2.73	2.16	2.13
P/FCF	18.78	23.92	20.96	18.35	9.64	9.9
EV/EBITDA	19.54	21.11	13.67	11.84	11.16	10.8
EV/Revenue	4.48	4.55	4.10	3.47	3.01	3.0
Earnings yield	1.6%	0.9%	4.1%	4.3%	4.0%	4.42%
FCF yield	5.3%	4.2%	4.8%	5.5%	10.4%	10.10%

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
LEVERAGE & SOLVENCY
Current ratio	1.41	1.88	1.61	1.91	1.98	1.69
Quick ratio	0.79	0.97	0.78	0.99	1.10	1.69
Debt / equity	0.56	0.47	0.46	0.50	0.59	0.59
Debt / assets	30.1%	27.0%	26.8%	29.0%	32.6%	32.8%
Net debt / EBITDA	4.12	3.56	2.41	2.52	3.12	3.02
Interest coverage	3.13	3.45	6.30	5.76	3.84	—

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Ratio	FY21	FY22	FY23	FY24	FY25	TTM
EFFICIENCY
Asset turnover	0.30	0.31	0.35	0.36	0.37	0.37
Receivables turnover	5.23	5.26	5.24	5.25	5.17	4.8
DSO (days)	70	69	70	69	71	76
DPO (days)	56	60	67	50	14	50
Cash conversion cycle	417	398	400	404	387	26
GROWTH (YoY)
Revenue growth	0.9%	-2.1%	6.5%	3.8%	7.2%	—
Net income growth	389.1%	-42.4%	342.5%	-11.7%	-22.0%	—
EPS growth	389.7%	-42.6%	345.1%	-7.9%	-21.3%	—
FCF growth	22.7%	-17.7%	8.7%	-4.2%	61.8%	—
PER SHARE ($)
EPS (diluted, TTM)	1.92	1.10	4.91	4.52	3.56	4.20
Book value / share	60.61	57.29	59.83	62.37	64.14	65.73
Revenue / share	33.93	33.08	35.45	38.41	41.55	44.27
FCF / share	6.38	5.23	5.71	5.72	9.33	9.52
Cash / share	1.81	1.79	1.99	2.63	2.99	2.13
SHAREHOLDER RETURN & SCORES
Buyback yield	0.0%	0.0%	2.8%	4.1%	1.4%	3.10%
Altman Z-Score	2.47	2.91	2.98	2.82	1.68	2.5
Piotroski F-Score	7	7	8	6	6	7/9
Beneish M-Score	-2.83	-2.65	-2.56	-2.58	-2.48	-2.59

Model	Score	Zone	Note
Piotroski F-Score	7 / 9	Strong
Altman Z-Score	2.5	Grey zone	Grey
Income quality	2.16	Cash-backed	OCF ÷ net income
Beneish M-Score	-2.59	Non-manipulator	vs −2.22 threshold

DuPont Decomposition (TTM)	Value
Tax burden	0.86
Interest burden	0.76
Operating margin	14.4%
Asset turnover	0.37×
Financial leverage	1.82×
= ROE	6%

Growth Quality (live)	Value
Revenue stability	0.66
Earnings stability	0.10
Earnings persistence	0.99
Revenue CAGR 3y	5.7%
EPS CAGR 3y	20.2%
FCF CAGR 3y	21.1%

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Buyback Yield3.10%

Dividend Yield1.01%

Total Shareholder Return4.15%cash yield

SBC / Revenue1.2%dilution pressure

Company	Mkt cap	P/E	ROE	Net margin	Rev growth	Piotroski	1-yr ret
PEN	$12.6B	78.4	11%	8.9%	+17.6%	6/9	+26.4%
SNN	$12.2B	19.0	22%	9.8%	+11.5%	8/9	-16.6%
ALGN	$10.5B	25.6	10%	10.3%	+4.4%	7/9	+13.5%
GMED	$10.3B	19.3	12%	19.2%	+19.7%	8/9	+30.9%
DXCM	$32.5B	33.2	38%	19.0%	+15.5%	9/9	—
PODD	$9.8B	26.3	26%	11.8%	+29.4%	9/9	—
GKOS	$9.7B	-50.7	-26%	-9.9%	+41.5%	3/9	—
BIO	$9.5B	42.5	3%	57.1%	+1.4%	7/9	—

1-yr returns computed from adjusted price history; peers without a tracked series show —.

Hold

42 Analysts

Str Sell (0)Sell (3)Hold (22)Buy (17)Str Buy (0)

Mean Target (qtr)$105.508 targets

Target vs. Price+11.1%last-quarter mean

Next Report2026-11-04street $1.88

Consensus estimates	Revenue mean	High / Low	EPS mean	High / Low	# EPS est.
FY2026	$8.60B	$8.61B / $8.56B	$8.53	$8.56 / $8.49	17
FY2027	$8.90B	$9.01B / $8.80B	$9.05	$9.41 / $8.84	17
FY2028	$9.25B	$9.40B / $9.05B	$9.71	$11.37 / $8.31	9

Street Price Target — Trajectory

Window	Avg Target	vs. Price	# Targets
Last Quarter	$105.50	+11.1%	8
Last Year	$100.79	+6.1%	24
All Time	$120.93	+27.3%	74

Rolling mean of published targets vs. last close $94.98. Aggregated from StreetInsider, Benzinga, Pulse 2.0.

Third-Party Composite Rating

B+

DCF

5/5

ROE

3/5

ROA

4/5

Debt/Eq

1/5

P/E

2/5

P/B

4/5

Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

ZBH -5.0% vs S&P 500 +15.9% — spread -20.8pp

Sector — XLV +24.2%

Peer Set — indexed to 100

All series indexed to 100 at the start of the window, adjusted closes.

Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Moving Average	Value	Distance	% Distance	Signal
SMA 20	$90.97	+4.01	+4.41%	Above
SMA 50	$95.23	-0.25	-0.26%	Below
SMA 200	$91.35	+3.63	+3.97%	Above
EMA 9	$92.20	+2.78	+3.02%	Above
EMA 21	$92.13	+2.85	+3.09%	Above
EMA 50	$93.11	+1.87	+2.01%	Above
EMA 200	$92.88	+2.10	+2.26%	Above

Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

TECHNICAL VERDICTBULLISHPower Score +3417 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%67

Momentum 25%91

Volume 20%50

Volatility 10%67

Patterns 15%50

This Week82% bullishof 11 price-based votes

4 Weeks Ago18%+64 pts since

12 Weeks Ago36%+46 pts since

ReadImprovingweek-over-week trajectory

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Price vs SMA 20$90.97

Price vs SMA 50$95.23

Price vs SMA 200$91.35

EMA 9/21 Cross92.2/92.1

SMA 50/200Golden

ADX DirectionADX 18

Supertrend$95

Parabolic SAR$88

SMA Slope-0.010

RSI57.5

Stochastic K/D84/80

StochRSI K/D98/97

Williams %R-11

CCI169

TSI vs Signal-5.4

CMO14.9

ROC7.57%

OBV SignalAccum

Chaikin MF-0.060

MFI41

Force Index1M

Elder Ray Bull3.78

RSI (14)30 oversold · 70 overbought

Stochastic %Kvs %D 80

Money Flowvolume-weighted RSI

ADXtrend strength · <20 weak

Williams %Rinverted scale

Level	Value	Level	Value
Pivot / R1 / R2	$94.15 / $95.08 / $95.77	S1 / S2	$93.46 / $92.53
Bollinger (20,2)	$86.80 – $95.14	Squeeze	Off
52-wk range	$79.12 – $106.88	Off 52-wk high	-11.1%
ATR (14)	$2.43 (2.6%)	Historical vol	29.1%

+3.1%Jan65%

+0.3%Feb50%

+0.7%Mar67%

+2.8%Apr55%

-1.3%May35%

-1.7%Jun25%

+2.3%Jul55%

-0.5%Aug40%

+0.1%Sep45%

-2.6%Oct45%

+0.7%Nov65%

+2.7%Dec85%

Sample: 20 years — treat short histories as suggestive, not statistical.

Computed from live weekly prices	ZBH	S&P 500
Weekly volatility (σ, 1y)	4.27%	1.83%
Best / worst week (1y)	+9.6% / -11.1%	—
Max drawdown (5y, monthly)	-50.1%	—
1-week VaR (95%)	-8.1%	—
Beta (5y)	0.47	1.00

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

ZBH EQUITY WEATHER (LIVE)RAINY · -17

Trend-23

Momentum+49

Volume-54

Volatility-60

Breadth-30

MARKET REGIME (2026-10-16)NEUTRAL

VIX19.99Normal

Dow TheoryConfirmed Bearish

SPY / QQQ TSI7.2 / 4.7trend strength

Sector Strength46/100breadth average

Average sentiment of 122 stories, weekly buckets, −1 to +1.

Overall-17.4+2.8 vs industry

Trend-22.7-0.6 vs industry

Momentum+49.2+71.2 vs industry

Volume-54.4-49.4 vs industry

Reading	ZBH	Medical - Devices n=524	Healthcare n=5,272	All US symbols n=70,435
Overall	-17.4	-20.2	-24.0	-20.5
Trend	-22.7	-22.1	-25.6	-21.3
Momentum	+49.2	-22.0	-28.5	-15.8
Volume	-54.4	-5.0	-25.0	-3.8

Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.

Executive	Total comp	Structure
Ivan Tornos Chairman, President and CEO	$16.1M	90% equity+incentive
Jehanzeb Noor SVP, Chief Strategy, Business	$7.9M	74% equity+incentive
Suketu Upadhyay CFO and EVP - Finance, Opera	$6.2M	83% equity+incentive
Kevin Thornal Group President, Global Busine	$6.2M	93% equity+incentive
Wilfred van Zuilen Group President, EMEA	$4.1M	66% equity+incentive

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Pillar (live disclosure scores)	Score
Environmental	66
Social	57
Governance	65
Composite ESG	63

Composite ESG Trend

Filed	8-K contents	Items
2026-09-08	Officer/Director Change; Regulation FD; Exhibits	5.02,7.01,9.01
2026-08-05	Earnings Release; Exhibits	2.02,9.01
2026-08-05	Other Events; Exhibits	8.01,9.01
2026-06-29	Material Agreement; Termination of Agreement; Financial Obligation; Ex	1.01,1.02,2.03,9.01
2026-05-27	Shareholder Vote; Exhibits	5.07,9.01
2026-05-12	Regulation FD; Exhibits	7.01,9.01
2026-04-28	Earnings Release; Exhibits	2.02,9.01
2026-04-28	Officer/Director Change; Regulation FD; Exhibits	5.02,7.01,9.01

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.

This space intentionally left blank — the next section begins on the following page

NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Data domain	Source	Coverage for this report
Price & volume	market_db.historical_prices	52 rows
Fundamentals	income_statements_annual	6 rows · 2020 to 2025
Reported vs consensus	fact/earnings_calendar	24 rows · 2020-11-06 to 2026-08-05
Analyst estimates	dim/forward_estimates	3 rows · 2026-12-31 to 2028-12-31
Institutional ownership (13F)	holdings_db.institutional_ownership_summary	101 rows · 2001 to 2026
Insider transactions (Form 4)	edgar/form4	12 rows · 2026-10-01
Proposed sales (Form 144)	edgar/form144	1 record
Beneficial ownership (13D/G)	edgar/13dg	4 rows · 2026-04-30 to 2026-08-13
Short-sale volume (FINRA)	edgar/short_volume_daily	60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)	edgar/darkpool_weekly	12 rows · 2026-06-15 to 2026-08-31
ETF & fund holding	etf_holdings_changelog (30d)	1 record
Peer set	stock_peers_dynamic	8 rows
Industry medians	industry_medians	1 record
Congressional trades	congress_db (House + Senate)	1 record
ESG	fact/esg_disclosures	1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.

Zimmer Biomet Holdings, Inc. (ZBH)

Score Breakdown

Peer Comparison — IS Score

IS Score Trend — quarterly

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)

Institutions holding — 12 quarters

Zimmer Biomet Holdings, Inc. (ZBH)

Monthly Net Insider Flow (000 shares)

Signal Summary

Zimmer Biomet Holdings, Inc. (ZBH)

2.8 · Largest Reporting 13F Managers

2.9 · Top ETF & Fund Ownership

13F Filers Holding ZBH — quarterly

Institutional Put/Call — quarterly

Zimmer Biomet Holdings, Inc. (ZBH)

Where ZBH Trades in the Dark

Zimmer Biomet Holdings, Inc. (ZBH)

3.8 · Employees (SEC filings)

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)

Balance Sheet — Full

Cash Flow Statement — Full

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)

Street Price Target — Trajectory

Third-Party Composite Rating

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)

Family Scores (site weights)

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)

Zimmer Biomet Holdings, Inc. (ZBH)